COMPANY
FDA-cleared device company
Keywords: diagnostics Aortic Stenosis Hyperkalemia Chronic Kidney Disease (Stage 3-4) AK-AVS AK+ Guard™ ECG Application
Profile checked Oct 10, 2026
Timeline
- Trial start —: ECG-based AI Screening for Cases of Undiagnosed Moderate-to-Severe Aortic Stenosis in the Primary Care Setting source ↗
- Trial start —: AK+ Guard™ Pilot Study in Chronic Kidney Disease: Outpatient Diagnostic Accuracy and Remote Monitoring source ↗
Upcoming milestones
- 2027-02 (ESTIMATED) · · ECG-based AI Screening for Cases of Undiagnosed Moderate-to-Severe Aortic Stenosis in the Primary Care Setting · NCT07827105
Estimated primary completion per ClinicalTrials.gov. Dates move.
Clinical trials (lead sponsor) 2
| Record | Title | Phase | Status | Start | Primary completion |
|---|
| NCT07827105 | ECG-based AI Screening for Cases of Undiagnosed Moderate-to-Severe Aortic Stenosis in the Primary Care Setting | Not listed | Enrolling by invitation | Aug 21, 2026 | 2027-02 (estimated) |
| NCT07210021 | AK+ Guard™ Pilot Study in Chronic Kidney Disease: Outpatient Diagnostic Accuracy and Remote Monitoring | Not listed | Recruiting | Oct 14, 2025 | 2025-11 (estimated) |
Connect
See your connections at AccurKardia on LinkedIn (search by name, results not checked)LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.
LinkedIn page linked from the company's own site: source · seen 2026-10-12
